20250922_LABS_Ringkasan Risalah//Risalah RUPS_31951342_lamp1.pdf

                      Agenda                        Attendance Quorum                    Percentage
                      Agenda 1                         2.859.435.500                        72,39%
                      Agenda 2                         2.859.435.500                        72,39%

           These shares were validated by an independent party (the Securities Administration Bureau). Thus, the
           quorum requirements as stipulated in the Company's Articles of Association and POJK have been met.


        E. Meeting Agenda
           1. Determination of salaries, honoraria, and other allowances for members of the Board of Directors
              and the Board of Commissioners of the Company.
           2. Changes in the composition of the Company’s Board of Directors and/or Board of Commissioners.

        F. Shareholders Question and Answer Session
              Prior to the decision making, the Chairman of the Meeting provided an opportunity for
              shareholders or shareholders' on their proxies present at the Meeting to ask questions and/or
              provide opinions for each item on the Meeting Agenda.

        G. Decision-Making Mechanism
               All resolutions of the Meeting were adopted based on deliberation for consensus. In the event that
               consensus could not be reached, resolutions were adopted by a majority vote of the valid votes
               cast at the Meeting. Voting was conducted through votes submitted by shareholders via eASY.KSEI
               application, proxies granted to representatives appointed by the Company’s Securities
               Administration Bureau, PT Bima Registra, as well as votes cast by shareholders physically present
               at the Meeting.

        H. Quorum for the Meeting Results
              For the Meeting Agendas, the quorum requirement referred to Article 23 paragraph
              (1) letter a of the Company's Articles of Association, which states that the Meeting may be held if
              attended by shareholders or their proxies representing more than 1/2 (one-half) of the total shares
              with valid voting rights issued by the Company.

        I. Voting Results for each Meeting Agenda
                   Agenda                    Accept                    Reject                  Abstain
                   Agenda 1              2.859.435.500                   0                       0
                   Agenda 2              2.859.435.500                   0                       0



        J. Resolutions of the Meeting Agenda were Approved as follows:

           •   First Agenda of the Meeting:
                To determine the salaries, honoraria, and/or other allowances for members of the Board of
                Directors and the Board of Commissioners of the Company for the 2025 financial year to be the
                same as those provided in the 2024 financial year, and to grant the authority to the Board of
                Commissioners’ Meeting to determine the allocation.




                                                                                                         Page 2 from 4




SUMMARY OF EGMS PT UBC MEDICAL INDONESIA TBK                                                               19th September 2025

           • Second Agenda of the Meeting

              a.   To appoint Mr. Raditia Nurcahya as Director of Operations of the Company, effective as of the
                   closing of this Meeting;

              b. To determine the composition of the Board of Directors and the Board of Commissioners of the
                 Company, effective as of the closing of this Meeting until the closing of the Annual General Meeting
                 of Shareholders of the Company in 2029, as follows:

                   Board of Directors:
                   President Director                   : Mr. FRANCISCUS XAVERIUS YOSHUA RAINTJUNG;
                   Director                             : Ms. MARCELLA ANGELIN;
                   Director of Operations               : Mr. RADITIA NURCAHYA;

                   Board of Commissioners:
                   President Commissioner               : Mr. NATHAN TIRTANA;
                   Independent Commissioner             : Mr. SUYANTO;

              c.   To grant authority and power to the Board of Directors of the Company, with the right of
                   substitution, to state/record the resolutions regarding the composition of the Board of Directors
                   and Board of Commissioners in a notarial deed, and subsequently to notify the relevant authorities,
                   and to carry out any and all necessary actions in connection with the resolutions in accordance with
                   the prevailing laws and regulations.



                                                     Jakarta, 22th September 2025
                                                  PT UBC MEDICAL INDONESIA TBK
                                                            Board Directors




                                                                                                           Page 3 from 4




SUMMARY OF EGMS PT UBC MEDICAL INDONESIA TBK                                                                 19th September 2025